GO:0004001 adenosine kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004001 adenosine kinase activity catalyzes the reversible transfer of a phosphate group from ATP to adenosine, yielding ADP and AMP.
• Adenosine kinase (ADK) is the principal intracellular enzyme that maintains low adenosine levels and thereby controls purinergic signaling.
• ADK exists as short (ADK-S) and long (ADK-L) isoforms; the long isoform localizes to the nucleus and modulates epigenetic marks through S-adenosylhomocysteine (SAH) and S-adenosylmethionine (SAM) balance.
• Altered ADK activity is implicated in cancer, epilepsy, and neurodegenerative conditions, making it a therapeutic target.
• ADK also detoxifies modified adenosines, coordinating with ADAL to protect cellular metabolism.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential for dissecting ADK function in health and disease.
Description
Adenosine kinase activity (GO:0004001) is a fundamental enzymatic function that regulates the cellular balance of adenosine, a key purinergic signaling molecule and metabolic intermediate. By catalyzing the phosphorylation of adenosine to AMP, adenosine kinase (ADK) acts as a metabolic gatekeeper, influencing processes ranging from neurotransmission to DNA methylation. Researchers study this activity to understand how cells maintain energy homeostasis, respond to stress, and regulate gene expression through epigenetic mechanisms. The enzyme is conserved across eukaryotes, with plant and insect orthologs providing insights into structural and regulatory diversity. In humans, ADK dysregulation has been linked to cancer, epilepsy, and inflammatory diseases, underscoring its clinical relevance. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of adenosine kinase activity, its molecular mechanism, associated genes, disease connections, and modern research methodologies.
adenosine kinase activity At A Glance
| GO ID | GO:0004001 |
|---|---|
| GO term | adenosine kinase activity |
| Ontology | molecular_function |
| Synonym | adenosine 5-phosphotransferase activity; adenosine kinase (phosphorylating); ATP:adenosine 5'-phosphotransferase activity |
| Definition | Catalysis of the reaction: ATP + adenosine = ADP + AMP. |
| Major function | Phosphorylation of adenosine to AMP, regulating adenosine levels and purine salvage. |
| EC number | 2.7.1.20 |
| Substrates | ATP and adenosine |
| Products | ADP and AMP |
What Is GO:0004001?
Adenosine kinase activity (GO:0004001) is defined by the Gene Ontology as the catalysis of the reaction: ATP + adenosine = ADP + AMP. In other words, it is the enzyme activity that transfers a phosphate group from ATP to adenosine, producing ADP and AMP. This activity is synonymous with adenosine 5-phosphotransferase, adenosine kinase (phosphorylating), and ATP:adenosine 5'-phosphotransferase. It is a molecular function that directly controls intracellular adenosine concentrations and feeds into purine salvage pathways.
Why Is adenosine kinase activity Important in Cell Biology?
Adenosine kinase activity is critical for maintaining the delicate balance of adenosine, a molecule that modulates neurotransmission, inflammation, and vascular tone. By phosphorylating adenosine, ADK prevents its accumulation and thereby controls the activation of adenosine receptors. This regulation is essential for normal physiology, and its disruption contributes to pathologies such as epilepsy, cancer, and ischemia-reperfusion injury. Moreover, the nuclear isoform ADK-L influences epigenetic programming by affecting the SAM/SAH ratio, linking adenosine metabolism directly to gene expression. Understanding adenosine kinase activity therefore offers a window into both metabolic and epigenetic regulation, with broad implications for therapeutic development.
• Regulates adenosine signaling, impacting neurotransmission, inflammation, and immune responses.
• Controls intracellular adenosine levels, preventing adenosine toxicity and maintaining purine homeostasis.
• Nuclear ADK-L modulates DNA and histone methylation via SAM/SAH balance, influencing epigenetic states.
• Dysregulation is associated with cancer progression and resistance to therapy.
• Inhibition of ADK is explored for epilepsy, pain, and inflammatory diseases.
• ADK activity affects sleep-wake cycles and cognitive function.
• Plant ADK is vital for cytokinin metabolism and stress responses.
• Insect ADK, such as from Bombyx mori, provides insights into development and immunity.
• ADK coordinates with ADAL to detoxify modified adenosines, safeguarding metabolism.
• ADK is a potential biomarker and drug target in multiple diseases.
Molecular Mechanism of adenosine kinase activity
Substrate Binding and Catalysis
In simple terms: Adenosine kinase grabs ATP and adenosine, then moves a phosphate from ATP onto adenosine.
Adenosine kinase catalyzes the transfer of the gamma-phosphate of ATP to the 5'-hydroxyl group of adenosine, forming AMP and ADP. The enzyme uses a sequential ordered mechanism where ATP binds first, followed by adenosine, and products are released in the order AMP then ADP. Structural studies of plant ADK reveal a monomer-dimer switch that modulates activity, with dimerization affecting substrate affinity. The catalytic mechanism requires divalent metal ions, typically Mg2+, for ATP coordination.
Isoforms and Subcellular Localization
In simple terms: There are two main versions of the enzyme: a short one in the cytoplasm and a long one in the nucleus.
In mammals, ADK exists as two isoforms: a short isoform (ADK-S) localized predominantly in the cytoplasm and a long isoform (ADK-L) that contains a nuclear localization signal and resides in the nucleus. ADK-S primarily regulates cytoplasmic adenosine levels and purine salvage, while ADK-L is involved in nuclear processes, including epigenetic regulation through modulation of the SAM/SAH ratio. The ratio of these isoforms is tissue-specific and changes in disease states.
Role in Purine Salvage and Adenosine Homeostasis
In simple terms: The enzyme recycles adenosine back into AMP, keeping adenosine levels low.
Adenosine kinase is a key enzyme in the purine salvage pathway, converting adenosine to AMP, which can then be rephosphorylated to ADP and ATP or used for nucleic acid synthesis. By maintaining low intracellular adenosine concentrations, ADK prevents the activation of adenosine receptors and modulates purinergic signaling. This function is especially important in the brain, where adenosine acts as a neuromodulator and regulates sleep, arousal, and seizure susceptibility.
Detoxification of Modified Adenosines
In simple terms: Adenosine kinase also helps break down unusual forms of adenosine that could be harmful.
Recent research shows that adenosine kinase, in coordination with ADAL (adenosine deaminase-like), detoxifies modified adenosines such as N6-methyladenosine (m6A) and other methylated derivatives. This detoxification pathway safeguards cellular metabolism by preventing the accumulation of potentially toxic modified nucleosides. The interplay between ADK and ADAL highlights a broader role for adenosine kinase in cellular defense mechanisms.
Regulation of Adenosine Kinase Activity
In simple terms: The enzyme's activity can be turned up or down by various cellular signals.
Adenosine kinase activity is regulated at multiple levels, including transcriptional control, alternative splicing, and post-translational modifications. The monomer-dimer switch in plant ADK suggests that oligomerization state can modulate activity. In mammals, ADK expression is influenced by factors such as hypoxia, inflammation, and circadian rhythms. Additionally, the enzyme's activity can be inhibited by small molecules, which is a focus for therapeutic development.
Key Genes Involved in GO:0004001 adenosine kinase activity
The following genes and proteins are directly associated with adenosine kinase activity or its regulatory network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADK | Encodes adenosine kinase; catalyzes adenosine phosphorylation | Central to adenosine homeostasis; target in epilepsy and cancer |
| ADAL | Adenosine deaminase-like; works with ADK to detoxify modified adenosines | Implicated in metabolic detoxification and nucleoside metabolism |
| ADA | Adenosine deaminase; degrades adenosine to inosine | Balances adenosine levels; deficiency causes SCID |
| ENT1 (SLC29A1) | Equilibrative nucleoside transporter 1; regulates adenosine uptake | Modulates intracellular adenosine available to ADK |
| ENT2 (SLC29A2) | Equilibrative nucleoside transporter 2 | Contributes to adenosine transport in various tissues |
| CD73 (NT5E) | Ecto-5'-nucleotidase; produces extracellular adenosine | Generates adenosine for ADK-dependent salvage |
| CD39 (ENTPD1) | Ectonucleoside triphosphate diphosphohydrolase 1; generates AMP | Works upstream of CD73 in adenosine production |
| A1R (ADORA1) | Adenosine receptor A1 | Mediates effects of adenosine regulated by ADK |
| A2AR (ADORA2A) | Adenosine receptor A2A | Involved in inflammation and neurodegeneration |
| A2BR (ADORA2B) | Adenosine receptor A2B | Linked to ischemic preconditioning and cancer |
| A3R (ADORA3) | Adenosine receptor A3 | Modulates immune responses and apoptosis |
| SAM (metabolite) | S-adenosylmethionine; methyl donor | Affected by ADK-L activity; links to epigenetics |
| SAH (metabolite) | S-adenosylhomocysteine; methylation inhibitor | Accumulates when ADK is inhibited; affects methylation |
| PRPP (metabolite) | Phosphoribosyl pyrophosphate; purine synthesis intermediate | Interconnects with salvage pathways |
| AMPK | AMP-activated protein kinase; energy sensor | Responds to AMP/ATP ratios influenced by ADK |
| mTOR | Mechanistic target of rapamycin; growth regulator | May be affected by adenosine-mediated signaling |
| Bombyx mori ADK | Insect adenosine kinase | Model for enzyme structure and function |
| Plant ADK | Plant adenosine kinase | Studied for cytokinin metabolism and stress responses |
How Is adenosine kinase activity Regulated?
Adenosine kinase activity is regulated at transcriptional, post-transcriptional, and post-translational levels. The ADK gene has multiple promoters and undergoes alternative splicing to produce ADK-S and ADK-L isoforms with distinct subcellular localizations and functions. Expression is induced by hypoxia, inflammation, and circadian signals. The monomer-dimer switch in plant ADK demonstrates that quaternary structure can modulate catalytic activity. Additionally, ADK activity can be inhibited by small-molecule inhibitors, which are being explored for therapeutic purposes. The enzyme's interplay with adenosine receptors and transporters further fine-tunes its effective activity in vivo.
adenosine kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADK | Epilepsy; seizures | ADK knockout mice, point-mutation knock-in mice |
| ADK | Cancer; immune evasion | Tumor cell lines with ADK overexpression or knockout |
| ADK | Sleep disorders; wakefulness | ADK conditional knockout in basal forebrain |
| ADK | Epigenetic regulation; metabolic disorders | ADK-L specific knockout or overexpression in cell lines |
| ADAL | Modified adenosine detoxification; metabolic stress | ADAL knockout cells, double knockout with ADK |
Adenosine Kinase in Cancer
Adenosine kinase expression and activity are altered in various cancers, where they contribute to tumor progression and immune evasion. High ADK levels can deplete extracellular adenosine, reducing antitumor immunity, while low levels may promote adenosine-mediated immunosuppression. Targeting ADK is considered a potential strategy to modulate the tumor microenvironment and enhance immunotherapy.
Adenosine Kinase and Neurological Disorders
In the brain, ADK regulates adenosine tone, which affects seizure susceptibility, sleep, and neuroprotection. Increased ADK expression is observed in epilepsy and is thought to contribute to seizure generation by lowering adenosine levels. Conversely, ADK inhibition has shown anticonvulsant and neuroprotective effects in preclinical models. Prolonged wakefulness alters ADK activity in specific brain regions, linking adenosine metabolism to sleep homeostasis.
Adenosine Kinase in Metabolic and Epigenetic Disorders
ADK-L, the nuclear isoform, influences epigenetic marks by modulating the SAM/SAH ratio, which affects DNA and histone methylation. Dysregulation of this pathway has been implicated in metabolic disorders and developmental abnormalities. Additionally, ADK cooperates with ADAL to detoxify modified adenosines, and defects in this pathway can lead to metabolic stress.
From adenosine kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of ADK loss on adenosine levels? | ADK knockout cell lines or mice |
| How does a specific ADK mutation affect catalysis? | Point-mutation knock-in of catalytic residues |
| What is the role of nuclear ADK-L in epigenetics? | Knock-in of tagged ADK-L for ChIP-seq |
| Can ADK overexpression protect against ischemia? | Overexpression of ADK in neuronal cultures |
| How does ADK inhibition affect tumor growth? | Xenograft models with ADK inhibitor treatment |
| What is the impact of ADK on sleep-wake cycles? | Conditional knockout in specific brain regions |
How to Study the adenosine kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiometric kinase assay | Conversion of radiolabeled adenosine to AMP | Enzyme kinetics and inhibitor screening |
| HPLC | Quantification of adenosine and nucleotides | Metabolic profiling in cell extracts |
| RNA-seq | Transcript levels of ADK and related genes | Expression analysis in disease models |
| Western blot | Protein expression and isoform detection | Validation of knockout or overexpression |
| Mass spectrometry | Metabolite concentrations (SAM, SAH, AMP, etc.) | Epigenetic and metabolic studies |
| Immunofluorescence | Subcellular localization of ADK isoforms | Nuclear vs cytoplasmic distribution |
| CRISPR screening | Identification of genes affecting adenosine sensitivity | Functional genomics of adenosine metabolism |
Enzymatic Activity Assays
Adenosine kinase activity can be measured using radiometric assays that monitor the conversion of [3H]adenosine to [3H]AMP, or by HPLC-based methods that quantify AMP production. These assays are essential for characterizing enzyme kinetics, inhibitor potency, and the effects of mutations.
Gene Expression Analysis
Quantitative RT-PCR, RNA-seq, and Western blotting are used to assess ADK mRNA and protein levels in tissues and cell lines. Isoform-specific primers or antibodies can distinguish ADK-S and ADK-L.
Metabolite Profiling
Mass spectrometry-based metabolomics allows quantification of adenosine, AMP, ADP, ATP, SAM, and SAH, providing a comprehensive view of the metabolic impact of ADK activity.
Imaging and Localization Studies
Fluorescence microscopy of GFP-tagged ADK or immunofluorescence with isoform-specific antibodies reveals subcellular localization and trafficking. PET imaging with ADK-specific tracers is being explored for in vivo studies.
How CRISPR Can Be Used to Study GO:0004001 adenosine kinase activity
Knockout
CRISPR-Cas9 knockout of ADK in cell lines or animal models abolishes adenosine kinase activity, leading to adenosine accumulation and altered purinergic signaling. These models are used to study the consequences of ADK loss in cancer, epilepsy, and metabolism.
Point Mutation
Introducing specific point mutations in the ADK catalytic domain via CRISPR base editing or homology-directed repair allows researchers to dissect the contribution of individual residues to catalysis and regulation. Such models help validate structural predictions and identify drug-resistant variants.
Knock-in
Knock-in of tagged ADK (e.g., FLAG, GFP) enables affinity purification, ChIP-seq, and live-cell imaging to study isoform-specific functions and interactions. Knock-in of disease-associated mutations can model human pathologies in mice or cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of ADK increases enzyme levels, allowing investigation of adenosine depletion effects on cell proliferation, immune evasion, and neuronal excitability. Overexpression models are valuable for target validation in cancer and neurological disorders.
How EDITGENE Supports adenosine kinase activity Research
Researchers studying adenosine kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as adenosine-mediated signaling, metabolic regulation, or disease progression. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides end-to-end services to generate these models and support functional studies.
Contact EDITGENE today to design your custom CRISPR model for adenosine kinase activity research.
Frequently Asked Questions About adenosine kinase activity
What is adenosine kinase activity?
Adenosine kinase activity (GO:0004001) is the enzymatic function that catalyzes the phosphorylation of adenosine to AMP using ATP, producing ADP.
What genes are involved in adenosine kinase activity?
The primary gene is ADK, which encodes adenosine kinase. Other related genes include ADAL, ADA, and adenosine receptors (ADORA1, ADORA2A, etc.).
What is the role of adenosine kinase in the brain?
In the brain, adenosine kinase regulates adenosine levels, affecting sleep, seizure susceptibility, and neuroprotection.
How is adenosine kinase activity measured?
It is typically measured using radiometric assays that monitor the conversion of radiolabeled adenosine to AMP, or by HPLC.
What diseases are associated with adenosine kinase?
Adenosine kinase is implicated in epilepsy, cancer, sleep disorders, and metabolic/epigenetic disorders.
Can adenosine kinase be targeted for therapy?
Yes, adenosine kinase inhibitors are being explored for epilepsy, pain, inflammation, and cancer.
What are the isoforms of adenosine kinase?
There are two main isoforms: ADK-S (short, cytoplasmic) and ADK-L (long, nuclear), which have distinct functions.
How does adenosine kinase affect epigenetics?
Nuclear ADK-L modulates the SAM/SAH ratio, influencing DNA and histone methylation.
What model systems are used to study adenosine kinase?
Common models include ADK knockout mice, cell lines with CRISPR knockout or overexpression, and plant/insect orthologs.
What is the relationship between adenosine kinase and ADAL?
ADK and ADAL cooperate to detoxify modified adenosines, protecting cellular metabolism.
Conclusion
Adenosine kinase activity (GO:0004001) is a central enzymatic function that governs adenosine homeostasis and purine salvage, with far-reaching implications for neurotransmission, immunity, epigenetics, and metabolism. Its dysregulation contributes to cancer, epilepsy, and other disorders, making it a promising therapeutic target. Advances in CRISPR-based models and multi-omics approaches are accelerating our understanding of ADK biology and its translational potential. Continued research into adenosine kinase activity will likely yield new insights into disease mechanisms and treatment strategies.
References
- 1. Ogawa A et al.. 2025. Adenosine kinase and ADAL coordinate detoxification of modified adenosines to safeguard metabolism.. Cell 188(22):6151-6169.e24 PMID: 40840445
- 2. Kopečný DJ et al.. 2025. A monomer-dimer switch modulates the activity of plant adenosine kinase.. J Exp Bot 76(12):3457-3479 PMID: 40063605
- 3. Zhulai G et al.. 2022. Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer.. Biomolecules 12(3) PMID: 35327609
- 4. Song K et al.. 2019. A Novel Adenosine Kinase from Bombyx mori: Enzymatic Activity, Structure, and Biological Function.. Int J Mol Sci 20(15) PMID: 31370143
- 5. Jarvis MF. 2019. Therapeutic potential of adenosine kinase inhibition-Revisited.. Pharmacol Res Perspect 7(4):e00506 PMID: 31367385
- 6. Boison D et al.. 2021. Adenosine kinase: A key regulator of purinergic physiology.. Biochem Pharmacol 187:114321 PMID: 33161022
- 7. Peter-Okaka U et al.. 2025. Adenosine Kinase: An Epigenetic Modulator and Drug Target.. J Inherit Metab Dis 48(3):e70033 PMID: 40393929
- 8. Alanko L et al.. 2003. Adenosine kinase and 5'-nucleotidase activity after prolonged wakefulness in the cortex and the basal forebrain of rat.. Neurochem Int 42(6):449-54 PMID: 12547643
